Article by Chemistfrog on Seeking Alpha on Unity Management Group's acquisition target. PPS picking up under low low volume! Once this hits the PR wire we'll throw some volume in the equation and then..... :)
Please click on link for full article, the following are excerpts:
MCC is a leader in instrumentation, data acquisition systems, high-speed production tablet press replication and tablet press control systems for the pharmaceutical industry, and has earned a reputation for technical excellence, quality service and client satisfaction. It was established in 1985 to serve companies that required outside help in technical programming. In 1986, Warner-Lambert commissioned MCC to create the first PC-based Tablet Press monitor. Today, MCC is an industry recognized expert in precision instrumentation and specializes in solid dosage form equipment. Much more can be viewed in the form of presentations and videos on its website at http://www.mcc-online.com/. The website itself, though relatively simple, lets one see the types of products and intellectual property that MCC Legacy possesses.
Unity Management’s upcoming finalization of the MCC purchase not only will provide it with approximately 2 million dollars in revenue, but it will also complement its existing three healthcare divisions. MCC Legacy’s customers will now become Unity Management’s customers and will greatly expand its clientele and exposure in the pharmaceutical and healthcare world. Per Unity Management’s press release announcing its letter of intention to acquire MCC, the following pharmaceutical companies were noted as MCC’s clientele: Pfizer, Merck, Bristol Meyers, Amgen, Bend Research, Purdue Pharma, Hoffman LaRoche, ISP, Boeringer Ingelheim , Exelixix, Watson Labs, Aqualon, Astra Zeneca, Schering-Ploughs, Novartis, Abbot Labs, JCMCO, Mendel company, Cobalt Pharma, Medelpharm, Patheon, Sanofi-Aventis, Barr Labs, Covidien Pharma, Forest labs, Azopharma, and Genzymebecome.
Although MCC Legacy has been out of the investors’ eyes due to its ownership by a private entity for the last couple of years, it apparently has not been out of the pharmaceutical world’s eyes as seen from the afore-mentioned list. It has been hard at work obtaining patents, presenting its products and intellectual products to the pharmaceutical industry and likely gaining more business. If one performs a search on the web for MCC Legacy Products he finds a myriad of presentations and PDF files. Following are some links to some very impressive documents and presentations that MCC Legacy either composed or had a large part in developing: (see links in actual article)
Unity Management will be closing on this acquisition any day now and should release a press release announcing such and other details. Unity recently became updated to “current status” on pink sheets, so we should see MCC Legacy’s financials if not with the press release announcing the completion of the acquisition then at least with the 3Q or 4Q 2010 financials. MCC Legacy will not only re-enter the investment world again as a publically held entity, but it will also be transparent in its financial reporting.
Investors will be closely watching Unity Management Group closely over the next few weeks as it grows and takes a solid foothold in the healthcare industry. Headlines from 2010 alone tell the story of Unity’s growth from acquisitions, stock retirement, stock buybacks, financial transparency, additions of key personnel and many other items to come. Unity Management Group, like MCC Legacy, is getting the attention of the investment world. It has transformed itself in one year to a key healthcare entity and will likely continue its torrid growth pace impressing not only investors but also the healthcare and pharmaceutical industries.
Great article by Chemistfrog (interesting name)! By the way, he's written like three or four on Unity Management on Seeking Alpha, all all are very good to great! Keep your eyes open for news coming soon on the acquisition. Once this completes and is announced we'll see some major movement in a company growing and taking care of business!
Volume & PPS starting to trend up on the final day(s) before the acquisition of MCC Legacy by Unity Management. We should see about 2 million in revenue picked up by Unity with this division which will be headed up by new COO Ron Berman who brings to UYMG big pharma and healthcare experience, knowledge and network of contacts (potential customers) ;).